“Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered.
To learn more about emerging developments, Digital Journal spoke with Marc Hedrick, MD MBA, President and CEO of Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system…”
Read the full article: https://bit.ly/3WkF4Wy
#BrainTumor #RadiationOncology #CancerResearch #ClinicalTrials #Radiotherapy #Neurosurgery #HealthScience #PrecisionMedicine #TherapeuticInnovation #MedicalAdvancements $PSTV
Recent Comments